Display options
Share it on

Results Immunol. 2012 Mar 30;2:72-82. doi: 10.1016/j.rinim.2012.03.002. eCollection 2012.

Antimicrobial peptide gene induction, involvement of Toll and IMD pathways and defense against bacteria in the red flour beetle, Tribolium castaneum.

Results in immunology

Kakeru Yokoi, Hiroaki Koyama, Chieka Minakuchi, Toshiharu Tanaka, Ken Miura

Affiliations

  1. Applied Entomology Laboratory, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa, Nagoya 464-8601, Japan.

PMID: 24371569 PMCID: PMC3862384 DOI: 10.1016/j.rinim.2012.03.002

Abstract

Using Tribolium castaneum, we quantitatively investigated the induction of nine antimicrobial peptide (AMP) genes by live gram-negative bacteria (Escherichia coli and Enterobacter cloacae), gram-positive bacteria (Micrococcus luteus and Bacillus subtilis) and the budding yeast (Saccharomyces cerevisiae). Then, five representative AMP genes were selected, and the involvement of the Toll and IMD pathways in their induction by E. coli, M. luteus and S. cerevisiae was examined by utilizing RNA interference of either MyD88 or IMD. Results indicated: Robust and acute induction of three genes by the two bacterial species was mediated mainly by the IMD pathway; slow and sustained induction of one gene by the two bacteria was mediated mainly by the Toll pathway; induction of the remaining one gene by the two bacteria was mediated by both pathways; induction of the five genes by the yeast was mediated by the Toll and/or IMD pathways depending on respective genes. These results suggest that more promiscuous activation and usage of the two pathways may occur in T. castaneum than in Drosophila melanogaster. In addition, the IMD pathway was revealed to dominantly contribute to defense against two bacterial species, gram-negative E. cloacae and gram-positive B. subtilis that possesses DAP-type peptidoglycan.

Keywords: AMP, antimicrobial peptide; Antimicrobial peptide; Att1, Attacin1; Att2, Attacin2; Att3, Attacin3; Bs, Bacillus subtilis; Cec2, Cecropin2; Cec3, Cecropin3; Col1, Coleoptericin1; Def1, Defensin1; Def2, Defensin2; Def3, Defensin3; Ec, Escherichia coli; Ecl, Enterobacter cloacae; FADD, Fas-associated death domain containing protein; GNBP, gram-negative binding protein; IMD pathway; Innate immunity; Ml, Micrococcus luteus; PAMP, pathogen-associated molecular pattern; PG, peptidoglycan; PGRP, peptidoglycan recognition protein; PRR, pattern recognition receptor; RNAi, RNA interference; RPL32, ribosomal protein L32; RT-PCR, reverse transcription-PCR; Sc, Saccharomyces cerevisiae; Toll pathway; Tribolium castaneum; dsRNA, double strand RNA; malE, maltose binding protein E; qRT-PCR, real-time quantitative RT-PCR

References

  1. EMBO Rep. 2000 Oct;1(4):353-8 - PubMed
  2. Science. 2002 Apr 12;296(5566):359-62 - PubMed
  3. Curr Opin Microbiol. 2002 Feb;5(1):102-10 - PubMed
  4. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2152-7 - PubMed
  5. J Biol Chem. 2000 Mar 17;275(11):7505-14 - PubMed
  6. Dev Cell. 2001 Oct;1(4):503-14 - PubMed
  7. J Immunol. 2002 Feb 15;168(4):1542-6 - PubMed
  8. Immunity. 2002 Nov;17(5):575-81 - PubMed
  9. J Biol Chem. 2008 Mar 21;283(12):7599-607 - PubMed
  10. EMBO Rep. 2000 Oct;1(4):347-52 - PubMed
  11. Mol Cell. 1999 Nov;4(5):827-37 - PubMed
  12. Proc Natl Acad Sci U S A. 2005 May 3;102(18):6455-60 - PubMed
  13. Cell. 2006 Dec 29;127(7):1425-37 - PubMed
  14. EMBO J. 2002 Jun 3;21(11):2568-79 - PubMed
  15. J Biol Chem. 2004 May 14;279(20):21121-7 - PubMed
  16. Annu Rev Immunol. 2007;25:697-743 - PubMed
  17. Curr Opin Immunol. 2003 Feb;15(1):12-9 - PubMed
  18. Mol Cell Biol. 2006 Nov;26(21):7821-31 - PubMed
  19. J Biol Chem. 2010 Oct 22;285(43):32937-32945 - PubMed
  20. Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13772-7 - PubMed
  21. Dev Comp Immunol. 2010 May;34(5):530-7 - PubMed
  22. Immunity. 2000 May;12(5):569-80 - PubMed
  23. Dev Comp Immunol. 1999 Jun-Jul;23(4-5):329-44 - PubMed
  24. Insect Biochem Mol Biol. 2002 Oct;32(10):1295-309 - PubMed
  25. Trends Immunol. 2008 Jun;29(6):263-71 - PubMed
  26. Immunity. 2000 Nov;13(5):737-48 - PubMed
  27. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14614-9 - PubMed
  28. J Biol Chem. 2000 Feb 18;275(7):4995-5002 - PubMed
  29. J Biol Chem. 2000 Dec 1;275(48):37373-81 - PubMed
  30. Curr Biol. 2002 Jun 25;12(12):996-1000 - PubMed
  31. J Biol Chem. 1996 Jun 7;271(23):13854-60 - PubMed
  32. Nature. 2008 Apr 24;452(7190):949-55 - PubMed
  33. FEBS J. 2008 Jun;275(11):2919-31 - PubMed
  34. FEBS J. 2005 Mar;272(5):1169-78 - PubMed
  35. Nat Immunol. 2003 Aug;4(8):794-800 - PubMed
  36. Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6602-7 - PubMed
  37. J Biol Chem. 2011 Sep 2;286(35):30284-30294 - PubMed
  38. Bioessays. 2000 May;22(5):469-80 - PubMed
  39. EMBO J. 2006 Oct 18;25(20):5005-14 - PubMed
  40. Genome Biol. 2007;8(8):R177 - PubMed
  41. Nat Immunol. 2004 Nov;5(11):1175-80 - PubMed
  42. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12654-8 - PubMed
  43. Dev Cell. 2006 Jan;10(1):45-55 - PubMed
  44. Nat Immunol. 2006 Jul;7(7):715-23 - PubMed
  45. Science. 2003 Dec 19;302(5653):2126-30 - PubMed
  46. J Biol Chem. 2006 Mar 24;281(12):7747-55 - PubMed
  47. Genome Biol. 2008 Jan 17;9(1):R10 - PubMed
  48. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14715-20 - PubMed
  49. Nature. 2003 Nov 6;426(6962):33-8 - PubMed
  50. Cell. 1993 Nov 19;75(4):753-63 - PubMed

Publication Types